(Q36646241)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087787%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Antidepressants and sexual dysfunction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087787%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087787%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Northey S

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087787%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Bhugra D

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087787%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087787%20AND%20SRC:MED&resulttype=core&format=json

Acta Psychiatrica Scandinavica

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087787%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087787%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087787%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

384-397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087787%20AND%20SRC:MED&resulttype=core&format=json

A population study of the association between sexual function, sexual satisfaction and depressive symptoms in men.

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Female Circumcision as a Public Health Issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Psychiatric morbidity is frequently undetected in patients with erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Prospective assessment of sexual function in women treated for recurrent major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Predictors of decreased libido in women during the late reproductive years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Erectile Dysfunction in Early, Middle, and Late Adulthood: Symptom Patterns and Psychosocial Correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Development of a rat model of sexual performance anxiety: effect of behavioural and pharmacological hyperadrenergic stimulation on APO-induced erections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Masturbatory guilt and sexual responsiveness among post-college-age women: sexual satisfaction revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Mediators of the Link between Childhood Sexual Abuse and Emotional Distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Prevalence and sequelae of sexual torture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Sexual dysfunction in the United States: prevalence and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Clinical pharmacology of MAO inhibitors: safety and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Women's issues in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

A cortical GABA-5HT interaction in the mechanism of action of the antidepressant trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

alpha(1)-Adrenoceptor antagonists. Rational design, synthesis and biological evaluation of new trazodone-like compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Neurochemical and psychotropic effects of bupropion in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Pramipexole in treatment-resistant depression: an extended follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Systematic review of sexual problems: epidemiology and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Response to Commentary: Using Questionnaires to Screen for Psychiatric Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Sexual dysfunction caused by reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Effects of obesity on women's reproduction and complications during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Options for pharmacological management of obesity in patients treated with atypical antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Valproate potentiates androgen biosynthesis in human ovarian theca cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Glucose dysregulation and mirtazapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Serotonin syndrome induced by a combination of bupropion and SSRIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Bupropion: risks and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Trazodone for erectile dysfunction: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Reversing anorgasmia associated with serotonin uptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Clinical experience with apomorphine hydrochloride: the first 107 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Pharmacological management of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Intermittent amantadine for fluoxetine-induced anorgasmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Characterization and function of histamine receptors in corpus cavernosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Investigations into the role of nitric oxide and the large intracranial arteries in migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

A chart review of cyproheptadine for stimulant-induced weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Apomorphine: an update of clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Amantadine-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Bethanecol chloride for treatment of clomipramine-induced orgasmic dysfunction in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Sildenafil for male erectile dysfunction: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Sildenafil (Viagra) for male erectile dysfunction: a meta-analysis of clinical trial reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Oral sildenafil (Viagra) in male erectile dysfunction: use, efficacy and safety profile in an unselected cohort presenting to a British district general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

The efficacy and safety of tadalafil: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Vardenafil reversal of female anorgasmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Andropause: is androgen replacement therapy indicated for the aging male?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

Hormone replacement therapy: controversies, pros and cons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

YOHIMBINE FOR ERECTILE DYSFUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00890.X

10.1111/J.1600-0447.2006.00890.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087787%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference